A1007 North American Dietary Supplements
Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.
Objective
The objective of this study was to assist our client, a European nutrition specialist, in planning the development of its strategy in North America in the dietary supplement market, more specifically in the area of cholesterol-lowering supplements.
The study provides an overview of the dietary supplement market with emphasis on the relevant cholesterol-lowering supplement market segment. This includes an analysis of market size by volume and value, market growth and market growth potential, key categories, geographic considerations, supply chain characteristics, competitors, competing products, key success factors, barriers to entry and some financial information relating to potential partners.
The report contains specific recommendations as to the best and most cost-effective approach to the market, and gives advice on approaches to competing in this attractive market.
Method
During the course of the study ~30 contacts were made with raw material suppliers, distributors and manufacturers of dietary supplements in the US, Canada and Europe. Interviews were conducted with those knowledgeable in the industry.
The main contents of the study were based on a large number of other sources including in-house databases, databases of dietary supplement products, government regulators, trade journals, patent databases, scientific journals and existing reports on the supplements market in North America.
Click to see the contents of the study or look below for an outline.
Table of Contents
Objective and Background
Method
Principal Findings
- Markets and CAGR
Value Chain
Sales Channels
Competition
Players
- Retail channel
Direct-marketing channel
Practitioner channel
Products
- US
Canada
Mexico
Views of Contacts
- Cholesterol-Lowering Market
Phytosterols
Marketing
Regulations and claims
R&D
Case Studies
Regulations
- US
Canada
Mexico
News
Pharmaceuticals
Conclusions
- Markets
Sales Channels
Competition
Marketing and Promotion
Products
Views of Contacts
Case Studies
Regulations
News
Pharmaceuticals
Recommendations
Key Success Factors
Swot For Client in Dietary Supplements
Summary of Spreadsheet Results
Markets
- Segmentation
- Vitamins
Minerals
Herbs & Botanicals
Specialty Supplements
Meal Supplements
Sports Nutrition
Sales Channels
- Retail Channels
Direct Channels
Size in Volume and Value
- Heart Health Supplements
The Supplements Value Chain
Players
- Summary
- Direct Marketing Channel
Practitioner Sales channel
Retail Supplement Companies
- 3 companies
Direct Selling Supplement Companies
- 9 companies
Practitioner Channel Sales in US
- 10 Companies
Cholesterol-Lowering Agents
- Prescription Drugs
- Statins (also known as HMG CoA reductase inhibitors)
Bile Acid Sequestrants (or also called Resins)
Nicotinic Acid
Fibrates
Ezetimibe
Supplements
- Artichoke leaf extract
Fenugreek
Fibre
Fish oil
Garlic
Ginseng
Guggul
Niacin
Red yeast rice
Soy protein
Phytosterol/Stanol Suppliers
Products
- Introduction
US Products
- 48 products
Canadian Players & Products
Mexico
- Players
Sales Channels
Regulations
- IADSA Framework
US
- Background
Labelling of Supplements Containing Sterols and Stanols
Canada
- Scope of the Natural Health Products Regulations
Main Components of the Natural Health Products Regulations
Guidance Documents
List of Included Substances
List of Excluded Substances
Dosage Form and Bulk Herbs
Hybrid Products
Activities Covered by the Natural Health Products Regulations
Mexico
- Background
Import Permits
Contact Reports
- Overview
- Market size and growth
Marketing
Regulations and claims
Case Study – Product A
Contact Reports
- 29 contacts
Case Studies
News Articles
- Summary
- Market
Recent Scientific Studies
Statins – a potential OTC threat
Competition
Consumer education & awareness
New product formulations
Brand recognition
Press Articles
- 25 articles
Patents
Focus on the Understanding of Coronary Heart Disease
- Introduction
How Coronary Heart Disease Originates
Incidence of CHD
Causes of CHD
Diagnosis of CHD
- Signs and Symptoms
Diagnostic Techniques
Treatments for CHD
Clinical Trials
Focus On Cholesterol and Cholesterol-Lowering Drugs
- Hypercholesterolemia and Coronary Heart Disease (CHD)
- Cholesterol Guidelines
Cholesterol in the Population
High blood pressure
Cholesterol Management
Clinical Trials of Cholesterol-Lowering Drugs
Summary
News on Pharmaceuticals
- Overview of Most Recent News
News Articles
- 55 articles
Examples of Research & Patents
- 4 items
114 Tables
17 Figures
Find us on: